1. Home
  2. SUPN vs COCO Comparison

SUPN vs COCO Comparison

Compare SUPN & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$49.87

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$53.94

Market Cap

3.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
COCO
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SUPN
COCO
Price
$49.87
$53.94
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$61.60
$56.75
AVG Volume (30 Days)
632.9K
552.1K
Earning Date
02-24-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
15.16
EPS
N/A
1.15
Revenue
$681,539,000.00
$609,286,000.00
Revenue This Year
$8.32
$18.41
Revenue Next Year
$23.64
$13.70
P/E Ratio
N/A
$46.47
Revenue Growth
4.54
23.12
52 Week Low
$29.16
$25.79
52 Week High
$57.65
$56.46

Technical Indicators

Market Signals
Indicator
SUPN
COCO
Relative Strength Index (RSI) 48.53 53.81
Support Level $49.41 $51.91
Resistance Level $52.34 $56.46
Average True Range (ATR) 1.62 1.87
MACD -0.21 -0.27
Stochastic Oscillator 38.94 50.69

Price Performance

Historical Comparison
SUPN
COCO

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

Share on Social Networks: